Jianing Lin
Phd Student
E-mail: jianing.lin@ki.se
Visiting address: CMM, Visionsgatan 18, 5 tr, 17176 Stockholm
Postal address: K8 Klinisk neurovetenskap, K8 Neuro Harris Lewandowski, 171 77 Stockholm
About me
I'm a phD student working on decoding the vascular dysfunction in amyotrophic lateral sclerosis (ALS), which is a devastating neurodegenerative disease with no curative therapies.
Research
My current research projects are mostly based on the original discovery from our group (Månberg A, et al. Nature Medicine. 2021), that perivascular fibroblast (PVF) activation proceeds disease onset and contributes to disease progression in ALS. I'm working to elucidate the possible mechanisms underlying PVF pathology in ALS, and to explore several ways to target PVF and related chemokines in treating the disease. Besides, I also look into other cell types during the arteriole dysfunction in ALS.
Articles
- Journal article: BMJ OPEN. 2022;12(9):e066402
- Journal article: BMC MEDICAL GENOMICS. 2022;15(1):173
- Journal article: ACTA NEUROLOGICA SCANDINAVICA. 2022;146(1):24-33
- Journal article: FRONTIERS IN NEUROLOGY. 2022;13:895321
- Journal article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2021;22(1-2):30-37
- Journal article: BRAIN, BEHAVIOR, AND IMMUNITY. 2020;88:97-104
- Journal article: EUROPEAN JOURNAL OF NEUROLOGY. 2020;27(6):1017-1022
- Journal article: FRONTIERS IN GENETICS. 2020;11:578143
Employments
- Phd Student, Department of Clinical Neuroscience, Karolinska Institutet, 2022-2026
Degrees and Education
- Master of Medicine, Neurology, Department of Neurology, First Affiliated Hospital of Sun Yat-sen University, 2022
- Bachelor of Medicine, Clinical Medicine, Zhongshan School of Medicine, Sun Yat-sen University, 2019
Conference/event participation
- Oral presenter of own accepted abstract, European Network to Cure ALS (ENCALS) meeting, ENCALS is a network of ALS centres in Europe., https://www.encals.eu/meetings/barcelona/, https://www.encals.eu/wp-content/uploads/2023/07/programa_DIGITAL_FINAL.pdf, 2023